Local Study Area definition

Local Study Area means the combined local authorities of Highlands, Moray, Aberdeenshire & Aberdeen City;
Sample 1Sample 2Sample 3
Local Study Area or “LSA” means the area surrounding and including the Project Development Area, where there is reasonable potential for immediate environmental and human impacts due to ongoing project activities;
Sample 1
Local Study Area means the Local Study Area referenced in Figure 12.
Sample 1

Examples of Local Study Area in a sentence

  • Site Study Area Local Study Area Regional Study AreaThe Site Study Area is the project footprint, as described above.The Local Study Area is defined as that area existing outside the Site Study Area boundary, where there is a reasonable potential for the occurrence of environmental effects from the project.

  • Discuss possible mitigation strategies to address: a) the need for, and plans to address, access management during and after Project operations; b) the process for addressing the needs of other land users in both the Project Area and the Local Study Area; c) measures to mitigate Project impacts on land use; and d) how potentially-affected aggregate reserves will be salvaged and stockpiled with input provided by Alberta Transportation and Alberta Sustainable Resource Development.

  • These changes can impact the aquatic resources including surface water flows, surface water quality and wetlands in the Local Study Area (LSA) and the Regional Study Area (RSA).

  • If you are not certain of the material suppliers, subcontractors, and laborers working on your project you may obtain a list from your contractor.

  • The Review Board determined the geographical scope of this environmental assessment to include Tamerlane’s Local Study Area (effectively the R-190 site)8 and all of the lands west of the Buffalo River that might be affected in some identifiable way by the development.

  • Not applicable YES NO Note: If you answered yes to any of the above questions, the application may be refused for filing under 21 CFR 314.101(d)(9).

  • The baseline (field data collection) and impact assessment will: o identify archaeological potential and archaeological sites present within the Local Study Area that could be potentially impacted by the project;o record in detail any archaeological site boundaries and all cultural materials or features encountered, either on the surface or subsurface; ando evaluate the scientific, public, ethnic, historic and/or economic significance of archaeological sites within the development area.

  • In July, we will use both alarm calls and juvenile food- begging calls to increase the potential for eliciting a response from goshawks in the Local Study Area.

  • Table 2-1: Ecological Landscape Classification of Vegetation Communities in the Local Study Area, 1994 and 2002 Land Cover TypeArea for 1994 Classification (ha)Area for 2002 Classification (ha)Bedrock- = Land cover type was not classified; ha=hectare.

  • Given the proximity ofthe noise study area to the public health area, it appears likelyThe Local Study Area for noise and vibration extends up to 750 feet from the railroad right-of-way, which is a standard study area for noise analysis.

Related to Local Study Area

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Development Area means that area to which a development plan is applicable.

  • Study Site means the location(s) under the control of the Institution where the Study is actually conducted as set out in Schedule 1.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • Study means the investigation to be conducted in accordance with the Protocol.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Phase I Trial means a Clinical Trial, the principal purpose of which is preliminary determination of safety of an investigational product in healthy individuals or patients or that otherwise meets the requirements described in 21 C.F.R. §312.21(a), or similar Clinical Trial in a country other than the United States.

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Clinical Trial means any human clinical trial of a Product.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Interconnection Study means any of the studies defined in the CAISO Tariff or, if applicable, any distribution provider’s tariff that reflect the methodology and costs to interconnect the Project to the Participating Transmission Owner’s electric grid.

  • Generation Interconnection Feasibility Study means a study conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) in accordance with Tariff, Part IV, section 36.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Interconnection Studies means the Interconnection Feasibility Study, the System Impact Study, and the Facilities Study described in Tariff, Part IV and Tariff, Part VI.

  • Phase 1 Study means a clinical study of a drug candidate in human patients with the primary objective of characterizing its safety, tolerability, and pharmacokinetics and identifying a recommended dose and regimen for future studies as described in 21 C.F.R. §312.21(a), or a comparable clinical study prescribed by the relevant Regulatory Authority in a country other than the United States. The drug candidate can be administered to patients as a single agent or in combination with other investigational or marketed agents.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Massive Multiauthor Collaboration Site (or “MMC Site”) means any World Wide Web server that publishes copyrightable works and also provides prominent facilities for anybody to edit those works. A public wiki that anybody can edit is an example of such a server. A “Massive Multiauthor Collaboration” (or “MMC”) contained in the site means any set of copyrightable works thus published on the MMC site.

  • Development Work means any work carried out in relation to the physical construction of a mine;

  • Phase III Trial means a Clinical Trial of an investigational product in subjects that incorporates accepted endpoints for confirmation of statistical significance of efficacy and safety with the aim to generate data and results that can be submitted to obtain Regulatory Approval as described in 21 C.F.R. 312.21(c), or a comparable Clinical Trial prescribed by the relevant Regulatory Authority in a country other than the United States.